Evidence map›Paper›PMID 25275585›Full record

ArticlePLoS pathogens2014

Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator.

Jie Qing, Yaxin Wang, Yuna Sun, Jiaoyan Huang, Wenzhong Yan, Jinglan Wang, Dan Su, Cheng Ni, Jian Li, Zihe Rao and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Advances in anti-EV-A71 drug development research.Journal of advanced research · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Enterovirus A71 antivirals: Past, present, and future.Acta pharmaceutica Sinica. B · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Jie QingTsinghua-Peking Center for Life Sciences, Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology (Ministry of Education), Department of Chemistry, Tsinghua University, Beijing, China; School of Medicine, Tsinghua University, Beijing, China.
Yaxin WangSchool of Medicine, Tsinghua University, Beijing, China; National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Science, Beijing, China.
Yuna SunNational Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Science, Beijing, China.
Jiaoyan HuangSchool of Medicine, Tsinghua University, Beijing, China.
Wenzhong YanSchool of Pharmacy, East China University of Science and Technology, Shanghai, China.
Jinglan WangSchool of Medicine, Tsinghua University, Beijing, China.
Dan SuCollaborative Innovation Center for Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
Cheng NiBeijing No. 4 High School, Beijing, China.
Jian LiSchool of Pharmacy, East China University of Science and Technology, Shanghai, China.
Zihe RaoSchool of Medicine, Tsinghua University, Beijing, China; National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Science, Beijing, China.
Lei LiuTsinghua-Peking Center for Life Sciences, Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology (Ministry of Education), Department of Chemistry, Tsinghua University, Beijing, China.
Zhiyong LouSchool of Medicine, Tsinghua University, Beijing, China; Collaborative Innovation Center for Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
Tsinghua University · CNEast China University of Science and Technology · CNInstitute of Biophysics · CNCenter for Life Sciences · CNShanghai Jinyuan Senior High School · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viruses utilize host factors for their efficient proliferation. By evaluating the inhibitory effects of compounds in our library, we identified inhibitors of cyclophilin A (CypA), a known immunosuppressor with peptidyl-prolyl cis-trans isomerase activity, can significantly attenuate EV71 proliferation. We demonstrated that CypA played an essential role in EV71 entry and that the RNA interference-mediated reduction of endogenous CypA expression led to decreased EV71 multiplication. We further revealed that CypA directly interacted with and modified the conformation of H-I loop of the VP1 protein in EV71 capsid, and thus regulated the uncoating process of EV71 entry step in a pH-dependent manner. Our results aid in the understanding of how host factors influence EV71 life cycle and provide new potential targets for developing antiviral agents against EV71 infection.

Indexed as

Antiviral AgentsCapsidCapsid ProteinsCyclophilin AEnterovirus A, HumanHumansVirus ReplicationAntiviral AgentsCapsid ProteinsCyclophilin A

Identifiers

PMID25275585
PMCPMC4183573
OpenAlexW2075266098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.